Reporting owner · Q3 2026 · CIK 1875714

Pieper Steven: insider trades.

Pieper Steven reported 4 non-derivative transactions on 3 SEC ownership filings in Q3 2026: 0 open-market purchases and 4 sales ($468K), across 1 company.

Transactions
4
Purchases (P)
0
Sales (S)
4
Companies
1
Name as filed
Pieper Steven

Companies

CompanyRelationshipTransactions
Xeris Biopharma Holdings, Inc. (XERS)Officer · See Remarks4

Transactions

4 non-derivative rows. Shares and prices as filed.
DateCompanyCodeSharesPriceOwned afterFiling
2026-09-01Xeris Biopharma Holdings, Inc.S5,000$8.51,356,053Form 4
2026-08-12Xeris Biopharma Holdings, Inc.S5,000$8.51,361,053Form 4
2026-07-07Xeris Biopharma Holdings, Inc.S27,600$8.521,366,053Form 4
2026-07-06Xeris Biopharma Holdings, Inc.S17,400$8.51,393,653Form 4

Questions

What stock did Pieper Steven buy or sell?

Pieper Steven reported 4 non-derivative transactions on 3 SEC ownership filings in Q3 2026: 0 open-market purchases and 4 sales ($468K), across 1 company.

Is Pieper Steven the same person as other filers with this name?

This page covers SEC CIK 1875714 only. The SEC assigns each reporting owner a CIK, and people with the same name have different CIKs.

Source: SEC Insider Transactions Data Sets, Q3 2026. Reported as filed; we do not assess intent, performance or compliance. All filings for this CIK on SEC.gov.

Plain-text version for agents and LLMs: /insiders/pieper-steven-1875714.md

Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.